Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Pfizer Inc

3rd Nov 2015 14:35

RNS Number : 4178E
Northern Trust Corporation
03 November 2015
 



 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Northern Trust Group

Company dealt in

Pfizer Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

2nd November 2015

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

87,259,512 1.41

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

87,259,512 1.41

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

Total

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD)

Buy

29

34.94

Buy

2910

35.06

Sell

381

34.84

Sell

1841

35.04

Sell

16071

35.06

Buy

1275

35.05

Buy

100

35.11

Sell

3

34.83

Sell

440

35.06

Sell

45

35.12

Buy

2

34.56

Buy

146

34.95

Buy

5205

35.04

Buy

118

35.10

Buy

328

35.13

Sell

5

34.80

Sell

8

34.82

Sell

12

34.85

Sell

8

34.87

Sell

1

34.88

Sell

4

34.97

Sell

27

34.99

Sell

4808

35.04

Sell

7

35.05

Sell

1

35.13

Sell

1

35.14

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

N/A

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

 3rd November 2015

Contact name

Paul Adair

Telephone number

020 7982 1236

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEBJBITMBJMBJA

Related Shares:

PFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96